Advanced search
Publication Cover
Hematology Volume 27, 2022 - Issue 1
Submit an article Journal homepage
3,902
Views
0
CrossRef citations to date
0
Altmetric
Case Report

False positive results: a challenge for laboratory physicians and hematologists in treating multiple myeloma with daratumumab

Shanshan Lianga Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, People’s Republic of China
,
Weihua Fenga Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, People’s Republic of China
,
Hongbing Mab Department of Hematology, West China Hospital, Sichuan University, Chengdu, People’s Republic of China
,
Li Zhangb Department of Hematology, West China Hospital, Sichuan University, Chengdu, People’s Republic of ChinaCorrespondence[email protected]
&
Chengyao Jiaa Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, People’s Republic of China
Pages 332-336 | Published online: 07 Mar 2022

References

  • Murata K, McCash SI, Carroll B, et al. Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral blood. Clin Biochem. 2018;51:66–71.
  • Kumar S, Paiva B, Anderson KC, et al. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016;17:e328–e346.
  • Guidelines for diagnosis and treatment of multiple Myeloma in China (revised in 2020). Chin J Int Med. 2020;59:341–346.
  • Dingli D, Ailawadhi S, Bergsagel PL, et al. Therapy for relapsed multiple myeloma: guidelines from the Mayo stratification for myeloma and risk-adapted therapy. Mayo Clin Proc. 2017;92(4):578–598.
  • Tang M, Zhao R, van de Velde H, et al. Myeloma cell dynamics in response to treatment supports a model of hierarchical differentiation and clonal evolution. Clin Cancer Res. 2016;22(16):4206–4214.
  • Ravi G, Andrade L, Vuyyala S, et al. Host and disease factors impacting presence of accessory band during therapy with daratumumab in multiple myeloma patients. Biol Blood Marrow Transplant. 2020;26(3):s390.
  • McCudden C, Axel AE, Slaets D, et al. Monitoring multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interference. Clin Chem Lab Med. 2016;54:1095–1104.
  • van de Donk NW, Otten HG, El Haddad O, et al. Interference of daratumumab in monitoring multiple myeloma patients using serum immunofixation electrophoresis can be abrogated using the daratumumab IFE reflex assay (DIRA). Clin Chem Lab Med. 2016;54:1105–1109.
  • McCudden CR, Jacobs JFM, Keren D, et al. Recognition and management of common, rare, and novel serum protein electrophoresis and immunofixation interferences. Clin Biochem. 2018;51:72–79.
  • Shah N, Aiello J, Avigan DE, et al. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma. J Immunother Canc. 2020;8:e000734.
  • Thoren KL, Pianko MJ, Maakaroun Y, et al. Distinguishing drug from disease by use of the Hydrashift 2/4 Daratumumab Assay. J Appl Lab Med. 2019;3(5):857–863.
  • Willrich MAV, Ladwig PM, Andreguetto BD, et al. Monoclonal antibody therapeutics as potential interferences on protein electrophoresis and immunofixation. Clin Chem Lab Med. 2016;54:1085–1093.
  • Moore LM, Cho S, Thoren KL. MALDI-TOF mass spectrometry distinguishes daratumumab from M-proteins. Clin Chim Acta. 2019;492:91–94.
  • Mills JR, Kohlhagen MC, Willrich MAV, et al. A universal solution for eliminating false positives in myeloma due to therapeutic monoclonal antibody interference. Blood. 2018;132:670–672.
  • Lynch C, Yen T, Trambas CM, et al. New laboratory protocol to identify iatrogenic IgG kappa monoclonal bands due to daratumumab therapy. Pathology. 2019;51:S113.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.